Update on PSA testing

Mark L Gonzalgo, H. Ballentine Carter

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The use of prostate-specific antigen (PSA) testing for prostate cancer screening has increased dramatically over the past decade. Determining the most efficient way to use PSA testing and how to interpret total PSA levels and changes in PSA values over time remain challenging. Guidelines for early detection of prostate cancer have a direct impact on the number of unnecessary tests performed and are critical for developing a successful screening approach for prostate cancer. The age at which PSA screening should begin, PSA testing intervals, and the importance of understanding fluctuations in PSA values over time are discussed in the framework of recent discoveries in the field. Results from ongoing randomized trials will confirm whether prostate cancer screening is an effective method for reducing deaths from prostate cancer and what approaches will provide the most cost-effective screening strategies.

Original languageEnglish (US)
Pages (from-to)737-742
Number of pages6
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume5
Issue number7
StatePublished - Aug 2007
Externally publishedYes

Fingerprint

Prostate-Specific Antigen
Prostatic Neoplasms
Early Detection of Cancer
Guidelines
Costs and Cost Analysis

Keywords

  • Outcomes
  • Prostate cancer
  • PSA
  • PSA velocity
  • Screening

ASJC Scopus subject areas

  • Oncology

Cite this

Update on PSA testing. / Gonzalgo, Mark L; Carter, H. Ballentine.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 5, No. 7, 08.2007, p. 737-742.

Research output: Contribution to journalArticle

Gonzalgo, Mark L ; Carter, H. Ballentine. / Update on PSA testing. In: JNCCN Journal of the National Comprehensive Cancer Network. 2007 ; Vol. 5, No. 7. pp. 737-742.
@article{c7cb9047d93a45b884b550f1a5487939,
title = "Update on PSA testing",
abstract = "The use of prostate-specific antigen (PSA) testing for prostate cancer screening has increased dramatically over the past decade. Determining the most efficient way to use PSA testing and how to interpret total PSA levels and changes in PSA values over time remain challenging. Guidelines for early detection of prostate cancer have a direct impact on the number of unnecessary tests performed and are critical for developing a successful screening approach for prostate cancer. The age at which PSA screening should begin, PSA testing intervals, and the importance of understanding fluctuations in PSA values over time are discussed in the framework of recent discoveries in the field. Results from ongoing randomized trials will confirm whether prostate cancer screening is an effective method for reducing deaths from prostate cancer and what approaches will provide the most cost-effective screening strategies.",
keywords = "Outcomes, Prostate cancer, PSA, PSA velocity, Screening",
author = "Gonzalgo, {Mark L} and Carter, {H. Ballentine}",
year = "2007",
month = "8",
language = "English (US)",
volume = "5",
pages = "737--742",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "7",

}

TY - JOUR

T1 - Update on PSA testing

AU - Gonzalgo, Mark L

AU - Carter, H. Ballentine

PY - 2007/8

Y1 - 2007/8

N2 - The use of prostate-specific antigen (PSA) testing for prostate cancer screening has increased dramatically over the past decade. Determining the most efficient way to use PSA testing and how to interpret total PSA levels and changes in PSA values over time remain challenging. Guidelines for early detection of prostate cancer have a direct impact on the number of unnecessary tests performed and are critical for developing a successful screening approach for prostate cancer. The age at which PSA screening should begin, PSA testing intervals, and the importance of understanding fluctuations in PSA values over time are discussed in the framework of recent discoveries in the field. Results from ongoing randomized trials will confirm whether prostate cancer screening is an effective method for reducing deaths from prostate cancer and what approaches will provide the most cost-effective screening strategies.

AB - The use of prostate-specific antigen (PSA) testing for prostate cancer screening has increased dramatically over the past decade. Determining the most efficient way to use PSA testing and how to interpret total PSA levels and changes in PSA values over time remain challenging. Guidelines for early detection of prostate cancer have a direct impact on the number of unnecessary tests performed and are critical for developing a successful screening approach for prostate cancer. The age at which PSA screening should begin, PSA testing intervals, and the importance of understanding fluctuations in PSA values over time are discussed in the framework of recent discoveries in the field. Results from ongoing randomized trials will confirm whether prostate cancer screening is an effective method for reducing deaths from prostate cancer and what approaches will provide the most cost-effective screening strategies.

KW - Outcomes

KW - Prostate cancer

KW - PSA

KW - PSA velocity

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=34547951151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547951151&partnerID=8YFLogxK

M3 - Article

C2 - 17692178

AN - SCOPUS:34547951151

VL - 5

SP - 737

EP - 742

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 7

ER -